BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 29521061)

  • 21. Prognostic value of initial QRS analysis in anterior STEMI: Correlation with left ventricular systolic dysfunction, serum biomarkers, and cardiac outcomes.
    López-Castillo M; Aceña Á; Pello-Lázaro AM; Viegas V; Merchán Muñoz B; Carda R; Franco-Peláez J; Martín-Mariscal ML; Briongos-Figuero S; Tuñón J
    Ann Noninvasive Electrocardiol; 2021 Jan; 26(1):e12791. PubMed ID: 32845542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of Selected Baseline and Post-PCI Electrocardiographic Parameters as Predictors of Left Ventricular Systolic Dysfunction after a First ST-Segment Elevation Myocardial Infarction.
    Fabiszak T; Kasprzak M; Koziński M; Kubica J
    J Clin Med; 2021 Nov; 10(22):. PubMed ID: 34830726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial.
    Ibanez B; Macaya C; Sánchez-Brunete V; Pizarro G; Fernández-Friera L; Mateos A; Fernández-Ortiz A; García-Ruiz JM; García-Álvarez A; Iñiguez A; Jiménez-Borreguero J; López-Romero P; Fernández-Jiménez R; Goicolea J; Ruiz-Mateos B; Bastante T; Arias M; Iglesias-Vázquez JA; Rodriguez MD; Escalera N; Acebal C; Cabrera JA; Valenciano J; Pérez de Prado A; Fernández-Campos MJ; Casado I; García-Rubira JC; García-Prieto J; Sanz-Rosa D; Cuellas C; Hernández-Antolín R; Albarrán A; Fernández-Vázquez F; de la Torre-Hernández JM; Pocock S; Sanz G; Fuster V
    Circulation; 2013 Oct; 128(14):1495-503. PubMed ID: 24002794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac troponin I for prediction of clinical outcomes and cardiac function through 3-month follow-up after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Hall TS; Hallén J; Krucoff MW; Roe MT; Brennan DM; Agewall S; Atar D; Lincoff AM
    Am Heart J; 2015 Feb; 169(2):257-265.e1. PubMed ID: 25641535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the usefulness of Doppler-derived deceleration time versus plasma brain natriuretic peptide to predict left ventricular remodeling after mechanical revascularization in patients with ST-elevation acute myocardial infarction and left ventricular systolic dysfunction.
    Cerisano G; Pucci PD; Valenti R; Boddi V; Migliorini A; Tommasi MS; Raspanti S; Parodi G; Antoniucci D
    Am J Cardiol; 2005 Apr; 95(8):930-4. PubMed ID: 15820157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The optimal time of B-type natriuretic peptide sampling associated with post-myocardial infarction remodelling after primary percutaneous coronary intervention.
    Choi H; Yoo BS; Doh JH; Yooh HJ; Ahn MS; Kim JY; Lee SH; Yoon J
    Cardiovasc J Afr; 2013 Jun; 24(5):165-70. PubMed ID: 24217163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum NT-proBNP on admission can predict ST-segment resolution in patients with acute myocardial infarction after primary percutaneous coronary intervention.
    Peng B; Xia H; Ni A; Wu G; Jiang X
    Herz; 2015 Sep; 40(6):898-905. PubMed ID: 25997425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized Control of Sympathetic Drive With Continuous Intravenous Esmolol in Patients With Acute ST-Segment Elevation Myocardial Infarction: The BEtA-Blocker Therapy in Acute Myocardial Infarction (BEAT-AMI) Trial.
    Er F; Dahlem KM; Nia AM; Erdmann E; Waltenberger J; Hellmich M; Kuhr K; Le MT; Herrfurth T; Taghiyev Z; Biesenbach E; Yüksel D; Eran-Ergöknil A; Vanezi M; Caglayan E; Gassanov N
    JACC Cardiovasc Interv; 2016 Feb; 9(3):231-240. PubMed ID: 26847114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of left ventricle diastolic function in myocardial infarction patients treated with primary angioplasty.
    Misztal M; Stopyra K; Gackowski A; Zmudka K; Piwowarska W
    Cardiol J; 2009; 16(5):440-6. PubMed ID: 19753523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. B-type natriuretic peptide and risk of contrast-induced acute kidney injury in acute ST-segment-elevation myocardial infarction: a substudy from the HORIZONS-AMI trial.
    Jarai R; Dangas G; Huber K; Xu K; Brodie BR; Witzenbichler B; Metzger DC; Radke PW; Yu J; Claessen BE; Genereux P; Mehran R; Stone GW
    Circ Cardiovasc Interv; 2012 Dec; 5(6):813-20. PubMed ID: 23192919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-contrast cardiac CT immediately after percutaneous coronary intervention: does it predict the risk of left ventricular remodeling in patients with ST-elevation myocardial infarction?
    Khurelsukh K; Kim YH; Seon HJ; Song JH; Park SY; Moon SM; Kim SH; Sim DS; Ahn Y
    Int J Cardiovasc Imaging; 2016 Jun; 32 Suppl 1():147-54. PubMed ID: 27139462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Admission B-type natriuretic peptide assessment improves early risk stratification by Killip classes and TIMI risk score in patients with acute ST elevation myocardial infarction treated with primary angioplasty.
    Grabowski M; Filipiak KJ; Malek LA; Karpinski G; Huczek Z; Stolarz P; Spiewak M; Kochman J; Rudowski R; Opolski G
    Int J Cardiol; 2007 Feb; 115(3):386-90. PubMed ID: 16860415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of attenuated plaque as detected by intravascular ultrasound on the occurrence of microvascular obstruction after percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
    Shiono Y; Kubo T; Tanaka A; Tanimoto T; Ota S; Ino Y; Aoki H; Ozaki Y; Orii M; Shimamura K; Ishibashi K; Yamano T; Yamaguchi T; Hirata K; Imanishi T; Akasaka T
    JACC Cardiovasc Interv; 2013 Aug; 6(8):847-53. PubMed ID: 23871509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Usefulness of N-terminal pro-B-type natriuretic peptide levels in predicting residual myocardial ischemia in patients with ST elevation acute myocardial infarction.
    Sarullo FM; Gristina T; Brusca I; Serio G; Taormina A; La Chiusa SM; Castello A; Borruso E; Paterna S; Di Pasquale P
    Minerva Cardioangiol; 2007 Apr; 55(2):149-55. PubMed ID: 17342035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Value of three dimensional-speckle tracking imaging for predicting left ventricular function after non-ST-segment elevation myocardial infarction with percutaneous coronary intervention.
    Luo Y; Liu Y; Guan X; Zhang Y; Li J
    J Xray Sci Technol; 2018; 26(2):331-339. PubMed ID: 29562571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Independent and cumulative association of clinical and morphological heart failure with long-term outcome after percutaneous coronary intervention.
    Kimura M; Kohno T; Sawano M; Heidenreich PA; Ueda I; Takahashi T; Matsubara T; Ueno K; Hayashida K; Yuasa S; Ohki T; Fukuda K; Kohsaka S
    J Cardiol; 2021 Jan; 77(1):41-47. PubMed ID: 32888830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased interleukin-1β levels are associated with left ventricular hypertrophy and remodelling following acute ST segment elevation myocardial infarction treated by primary percutaneous coronary intervention.
    Ørn S; Ueland T; Manhenke C; Sandanger Ø; Godang K; Yndestad A; Mollnes TE; Dickstein K; Aukrust P
    J Intern Med; 2012 Sep; 272(3):267-76. PubMed ID: 22243053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Chia S; Senatore F; Raffel OC; Lee H; Wackers FJ; Jang IK
    JACC Cardiovasc Interv; 2008 Aug; 1(4):415-23. PubMed ID: 19463339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Repeated echocardiography after first ever ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention--is it necessary?
    Søholm H; Lønborg J; Andersen MJ; Vejlstrup N; Engstrøm T; Møller JE; Hassager C
    Eur Heart J Acute Cardiovasc Care; 2015 Dec; 4(6):528-36. PubMed ID: 25318482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic impact of neutrophil gelatinase-associated lipocalin and B-type natriuretic in patients with ST-elevation myocardial infarction treated by primary PCI: a prospective observational cohort study.
    Helanova K; Littnerova S; Kubena P; Ganovska E; Pavlusova M; Kubkova L; Jarkovsky J; Pavkova Goldbergova M; Lipkova J; Gottwaldova J; Kala P; Toman O; Dastych M; Spinar J; Parenica J
    BMJ Open; 2015 Oct; 5(10):e006872. PubMed ID: 26438132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.